Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Mosier

Orthopaedic Surgery Monroeville, PA Medical Doctor

NPI 1538417274 CMS profile 976713

2550 Mosside Blvd, Suite 405, Monroeville, PA 15146

Open in the dashboard

General payments

$36,043

58 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$73,393 paid to institutions, not to them · program years 2021–2024

Through program year 2025, Brian Mosier of Monroeville, PA is reported in the CMS Open Payments database as having received $36,043 across 58 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $73,393 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $357 6
2024 General $13,580 8
2023 General $7,281 8
2022 General $6,621 13
2021 General $3,489 5
2020 General $2,215 8
2019 General $2,500 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Mosier
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Brian Mosier were reported at $357. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Brian Mosier Orthopaedic Surgery median Middle half National median
2019 $2,500 $644 $140–$2,844 $163
2020 $2,215 $312 $75–$1,860 $114
2021 $3,489 $520 $117–$2,495 $132
2022 $6,621 $598 $128–$2,731 $149
2023 $7,281 $461 $128–$2,264 $160
2024 $13,580 $497 $134–$2,475 $164
2025 $357 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Vericel Corporation $30,427 30 payments
  2. Mid-Atlantic Surgical Systems, LLC $4,738 14 payments
  3. Innovation Technologies Inc $182 4 payments
  4. Arthrex, Inc. $154 2 payments
  5. Zimmer Biomet Holdings, Inc. $133 1 payment
  6. Medtronic USA, Inc. $114 1 payment
  7. Sanara MedTech Inc. $80 1 payment
  8. Biocomposites Inc $73 1 payment
  9. Aesculap Biologics, LLC $62 1 payment
  10. Teleflex LLC $31 1 payment
  11. Other $48 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $25,728 8 payments
  2. Education $4,507 5 payments
  3. Food and Beverage $1,834 38 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $1,650 1 payment
  5. Travel and Lodging $1,224 5 payments
  6. Honoraria $1,100 1 payment
Products named General payments · program years 2019–2025
  1. MACI Orthopedics $20,424 16 payments
  2. MACI Cellular Therapy $2,323 8 payments
  3. MACI Cellular Therapy $2,270 3 payments
  4. Irrisept $182 4 payments
  5. PlasmaBlade $114 1 payment
  6. CellerateRx $80 1 payment
  7. Stimulan $73 1 payment
  8. NOVOCART 3D $62 1 payment
  9. DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE ANKLE FRACTURE $50 1 payment
  10. UROLIFT $31 1 payment
  11. Other $48 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$65,416

Of which drugs: $376

Medicare patients

212

Average age 73

Services billed

3,412

126 women, 86 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Ischemic heart disease 29%
Diabetes 28%
Depression 25%
COPD 20%
Chronic kidney disease 19%
Atrial fibrillation 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 50 2,720 $278
Injection, methylprednisolone acetate, 40 mg J1030 Office 18 18 $76

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

58 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record